The strain M-43 was isolated from the Oncorhynchus mykiss from a fish farm in Mugla, Turkey. Pairwise 16S rRNA gene sequence analysis was used to identify strain M-43. The strain was a member of the genus Myroides sharing the highest 16S rRNA gene sequence identity levels of 98.7%, 98.3%, and 98.3% with the type strains of M. profundi D25, M. odoratimimus subsp. odoratimimus CCUG 39352 and M. odoratimimus subsp. xuanwuensis DSM27251, respectively. A polyphasic taxonomic approach including whole genome-based analyses was employed to confirm the taxonomic provenance of strain M-43 within the genus Myroides. The overall genome relatedness indices (OGRI) for strain M-43 compared with its most closely related type strains M. odoratimimus subsp. xuanwuensis DSM 27251, M. profundi D25, and M. odoratimimus subsp. odoratimimus ATCC BAA-634, were calculated as 25.3%, 25.1%, and 25% for digital DNA-DNA hybridization (dDDH), 83.3%, 83.6%, and 83.4% for average nucleotide identity (ANI) analyses, respectively. The OGRI values between strain M-43 and its close neighbors confirmed that the strain represents a novel species in the genus Myroides. The DNA G + C content of the strain is 33.7%. The major fatty acids are iso-C and summed feature 9 (iso-C ω9c and/or 10-methyl C). The predominant polar lipids are phosphatidylethanolamine, an amino-lipid and five unidentified lipids. The major respiratory quinone is MK-6. Chemotaxonomic and phylogenomic analyses of this isolate confirmed that the strain represents a novel species for which the name Myroides oncorhynchi sp. nov. is proposed, with M-43 as the type strain (JCM 34205 = KCTC 82265).

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10482-022-01804-xDOI Listing

Publication Analysis

Top Keywords

strain m-43
20
odoratimimus subsp
16
genus myroides
12
strain
10
myroides oncorhynchi
8
oncorhynchi nov
8
oncorhynchus mykiss
8
16s rrna
8
rrna gene
8
gene sequence
8

Similar Publications

Beneficial/probiotic strains protect the host from pathogens by competitive displacement and production of antibacterial substances, i.e., bacteriocins.

View Article and Find Full Text PDF

Probiotics plus vitamin D in irritable bowel syndrome: a prospective multicentric non-interventional study.

Minerva Gastroenterol (Torino)

September 2024

Mayoly Spindler Laboratories, Department of Medical Affairs, Chatou, France.

Background: Patients with irritable bowel syndrome (IBS) experience recurrent symptoms and anxiety disorders that significantly impact their quality of life (QoL). The aim of the study was to assess in daily practice the benefit of the combination of three probiotic strains (Lactobacillus plantarum CETC 7484 and CETC 7485; Pediococcus acidilactici CECT 7483) plus vitamin D in patients with diarrhea-predominant IBS (IBS-D) or IBS with mixed bowel movements (IBS-M).

Methods: This was a prospective, multicenter, non-interventional study in adult patients with IBS-D or IBS-M (Rome IV criteria) followed by private-practice gastroenterologists.

View Article and Find Full Text PDF

Background: Small ruminants have a socioeconomic impact on Egypt's production of meat, milk, and wool. Hence, every effort should be taken to prevent infections.

Aim: To elucidate the prevalence and serogrouping of () strains from diarrheic lambs and kids, determine their antibiotic susceptibility and associated risk factors affecting the occurrence of the disease, and establish the most common virulence genes marker and major antimicrobial resistance genes.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores the potential of repurposing six antiretroviral drugs to treat COVID-19 by evaluating their antiviral effects against SARS-CoV-2 in lab settings.
  • The researchers conducted various tests, including cytotoxicity assays and molecular docking, to assess the drugs' effectiveness and their interactions with key viral proteins.
  • Results indicated that lamivudine, emtricitabine, and raltegravir were effective against SARS-CoV-2, with raltegravir showing the most promise at lower concentrations, but further studies are needed to evaluate its use in COVID-19 patients.
View Article and Find Full Text PDF

The strain M-43 was isolated from the Oncorhynchus mykiss from a fish farm in Mugla, Turkey. Pairwise 16S rRNA gene sequence analysis was used to identify strain M-43. The strain was a member of the genus Myroides sharing the highest 16S rRNA gene sequence identity levels of 98.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!